Brief: Sab Biotherapeutics Announces Private Placement Of Up To $130 Million

SAB Biotherapeutics

02/10/2023 13:29

Oct 2 (Reuters) - SAB Biotherapeutics Inc  SABS.O :
    * SAB BIOTHERAPEUTICS ANNOUNCES PRIVATE PLACEMENT OF UP TO
$130
MILLION TO ADVANCE DEVELOPMENT OF LEAD DRUG CANDIDATE FOR TYPE 1
DIABETES
    * SAB BIOTHERAPEUTICS: OFFERING TO PROVIDE UP TO $130
MILLION IN
GROSS PROCEEDS TO SAB, WHICH WILL BE USED TO FUND COMPANY'S LEAD
RESEARCH PROGRAM, SAB-142
    * SAB BIOTHERAPEUTICS INC - FULL PROCEEDS, WHEN FUNDED, ARE
EXPECTED TO FUND COMPANY THROUGH 2026 AND TOPLINE PHASE II
RESULTS

Source text for Eikon:  ID:nGNX54NNVH 
Further company coverage:  SABS.O 

 ((Reuters.Briefs@thomsonreuters.com;))